Login / Signup

Non-VKA Oral Anticoagulants in Adult Congenital Heart Disease: a Single-Center Study.

Pedro Garcia BrásTânia Branco ManoTiago RitoAlexandra CasteloVera FerreiraAna AgapitoRui Cruz FerreiraFatima PintoLídia de Sousa
Published in: Cardiovascular drugs and therapy (2022)
In this real-life cohort of selected ACHD, the use of NOACs was safe and effective, with a low incidence of bleeding events.
Keyphrases
  • oral anticoagulants
  • congenital heart disease
  • atrial fibrillation
  • risk factors
  • childhood cancer